UBS ASSET MANAGEMENT AMERICAS LLC - ASTEX PHARMACEUTICALS INC ownership

ASTEX PHARMACEUTICALS INC's ticker is ASTX and the CUSIP is 04624B103. A total of 123 filers reported holding ASTEX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ASTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2013$222,000
+105.6%
26,2000.0%0.00%
Q2 2013$108,00026,2000.00%
Other shareholders

There were no reported owners of ASTEX PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of ASTEX PHARMACEUTICALS INC shareholders